Stonepine Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-46,886	Closed	-$125K	–	32
2021 Q2	$125K	Sell	46,886 -269,393	-85%	-$718K	0.07%	24
2021 Q1	$974K	Buy	+316,279	New	+$974K	0.53%	25